TreeFrog Therapeutics 在生物反应器中生产大规模帕金森细胞疗法，在临床前模型中实现完全康复。 TreeFrog Therapeutics produces large-scale Parkinson's cell therapy in a bioreactor, achieving full recovery in pre-clinical models.

据"神经治疗学杂志"详细报道,TreeFrog Therapeutics在生物反应器中首次成功大规模生产了帕金森病细胞治疗. TreeFrog Therapeutics has reported the first successful large-scale production of a Parkinson's disease cell therapy in a bioreactor, as detailed in the Neurotherapeutics Journal. 该研究在采用独特的3D微组织格式进行16周移植后,在临床前模型中实现了完全的行为恢复。 The study achieved full behavioral recovery in pre-clinical models after 16 weeks of transplantation using a unique 3D microtissue format. 这一创新办法解决了以往工业化的挑战,为病人提供了有希望的解决办法,有可能使单一生物反应器中的数百人得到治疗。 This innovative approach addresses previous industrialization challenges and offers a promising solution for patients, potentially enabling the treatment of hundreds from a single bioreactor.